Nanhua Bio Medicine Co Ltd Cash Flow-to-Debt Ratio
Nanhua Bio Medicine Co Ltd cash flow-to-debt ratio. Nanhua Bio Medicine Co Ltd (000504) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥22.42 Million could theoretically repay 0% of its total liabilities (CN¥479.30 Million) in one year. Check Nanhua Bio Medicine Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Nanhua Bio Medicine Co Ltd (1998–2025)
Cash flow-to-debt ratio of Nanhua Bio Medicine Co Ltd from 1998 to 2025. Historical debt coverage capacity for Nanhua Bio Medicine Co Ltd across 28 annual periods. Check 000504 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Nanhua Bio Medicine Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Nanhua Bio Medicine Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Nanhua Bio Medicine Co Ltd. For the full cash flow conversion analysis, see how efficiently does Nanhua Bio Medicine Co Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | CN¥-115.74 Million | CN¥634.22 Million | ▼ -1341.7% |
| 2024 | 0.01x | CN¥4.79 Million | CN¥326.17 Million | ▼ -81.1% |
| 2023 | 0.08x | CN¥36.28 Million | CN¥466.71 Million | ▼ -77.9% |
| 2022 | 0.35x | CN¥166.38 Million | CN¥473.18 Million | ▲ +80.2% |
| 2021 | 0.20x | CN¥107.10 Million | CN¥548.93 Million | ▲ +139.7% |
| 2020 | -0.49x | CN¥-207.22 Million | CN¥421.66 Million | ▼ -620.7% |
| 2019 | 0.09x | CN¥14.52 Million | CN¥153.87 Million | ▲ +246.0% |
| 2018 | -0.06x | CN¥-15.19 Million | CN¥234.95 Million | ▲ +62.3% |
| 2017 | -0.17x | CN¥-47.40 Million | CN¥276.34 Million | ▼ -160.1% |
| 2016 | -0.07x | CN¥-14.60 Million | CN¥221.43 Million | ▲ +47.3% |
| 2015 | -0.13x | CN¥-17.17 Million | CN¥137.26 Million | ▲ +61.8% |
| 2014 | -0.33x | CN¥-32.60 Million | CN¥99.61 Million | ▼ -241.0% |
| 2013 | -0.10x | CN¥-11.74 Million | CN¥122.32 Million | ▼ -117.5% |
| 2012 | -0.04x | CN¥-4.28 Million | CN¥96.86 Million | ▼ -106.5% |
| 2011 | -0.02x | CN¥-3.12 Million | CN¥146.09 Million | ▲ +95.8% |
| 2010 | -0.51x | CN¥-63.95 Million | CN¥125.69 Million | ▼ -326.2% |
| 2009 | 0.22x | CN¥60.28 Million | CN¥267.95 Million | ▲ +412.7% |
| 2008 | -0.07x | CN¥-18.59 Million | CN¥258.36 Million | ▼ -281.4% |
| 2007 | 0.04x | CN¥9.22 Million | CN¥232.31 Million | ▲ +970.8% |
| 2006 | 0.00x | CN¥717.62K | CN¥193.70 Million | ▼ -93.4% |
| 2005 | 0.06x | CN¥11.40 Million | CN¥202.16 Million | ▼ -32.2% |
| 2004 | 0.08x | CN¥13.31 Million | CN¥160.03 Million | ▼ -74.3% |
| 2003 | 0.32x | CN¥55.75 Million | CN¥172.25 Million | ▲ +375.8% |
| 2002 | 0.07x | CN¥15.83 Million | CN¥232.77 Million | ▼ -44.6% |
| 2001 | 0.12x | CN¥34.22 Million | CN¥278.69 Million | ▲ +871.8% |
| 2000 | -0.02x | CN¥-3.36 Million | CN¥211.30 Million | ▼ -151.9% |
| 1999 | -0.01x | CN¥-1.93 Million | CN¥305.96 Million | ▼ -153.0% |
| 1998 | 0.01x | CN¥3.32 Million | CN¥278.36 Million | — |